Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Masimo Corporation (MASI:NASDAQ), powered by AI.
Masimo Corporation is currently trading at $179.95. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Masimo Corporation on Alpha Lenz.
Masimo Corporation's P/E ratio is -63.7.
“Masimo Corporation trades at a P/E of -63.7 (undervalued) with modest ROE of -17.1%. Operating margin of 20.5% indicates strong profitability.”
Ask for details →Masimo Corporation is a global leader in noninvasive monitoring technologies, specifically focusing on developing innovative medical devices that improve patient outcomes and reduce the cost of care. The company's flagship product line includes advanced signal processing pulse oximetry devices, which are pivotal in accurately measuring oxygen levels, pulse rate, and other vital signals without the need for invasive procedures. Masimo's technology is widely adopted across various healthcare settings including hospitals, outpatient treatment centers, and alternative care sites, enhancing patient monitoring and aiding clinicians in detecting potential health issues more efficiently. Besides, Masimo’s products are recognized for their precision and reliability, demonstrating robustness even in challenging clinical environments where motion and low perfusion can affect monitoring accuracy. The corporation is committed to expanding its technological suite, covering a spectrum of health monitoring solutions that contribute to improved healthcare practices globally. Based in Irvine, California, Masimo's ongoing innovation continues to set benchmarks in the healthcare industry, influencing a wide range of sectors from emergency care to surgical and critical care monitoring.
“Masimo Corporation trades at a P/E of -63.7 (undervalued) with modest ROE of -17.1%. Operating margin of 20.5% indicates strong profitability.”
Ask for details →Masimo Corporation (ticker: MASI) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 3,600 employees. Market cap is $9.6B.
The current price is $179.95 with a P/E ratio of -63.67x and P/B of 13.37x.
ROE is -17.09% and operating margin is 20.49%. Annual revenue is $1.5B.